The latest price target for Cohen & Steers (NYSE:CNS) was reported by Evercore ISI Group on November 7, 2024. The analyst firm set a price target for $111.00 expecting CNS to rise to within 12 months (a possible 11.39% upside). 9 analyst firms have reported ratings in the last year.

The latest analyst rating for Cohen & Steers (NYSE:CNS) was provided by Evercore ISI Group, and Cohen & Steers maintained their outperform rating.

The last upgrade for Cohen & Steers Inc happened on October 17, 2024 when UBS raised their price target to $102. UBS previously had a sell for Cohen & Steers Inc.

There is no last downgrade for Cohen & Steers.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cohen & Steers, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cohen & Steers was filed on November 7, 2024 so you should expect the next rating to be made available sometime around November 7, 2025.

While ratings are subjective and will change, the latest Cohen & Steers (CNS) rating was a maintained with a price target of $110.00 to $111.00. The current price Cohen & Steers (CNS) is trading at is $99.65, which is out of the analyst’s predicted range.